KPMA, NHIC raise battle for insurance drugs' price comparison

The Korea Pharmaceutical Manufacturers Association (KPMA) and the National Health Insurance Corporation (NHIC) are clashing head-on over the KPMA's report that Korea's top 500-drug prices covered by the national health insurance is in the level of 57.1 percent compared with those of seven advanced countries (A7).

The NHIC rebuffed the KPMA's claims as groundless, saying the composition of in...